Literature DB >> 29882088

Spironolactone rescues renal dysfunction in obstructive jaundice rats by upregulating ACE2 expression.

Er-Liang Kong1, Jin-Min Zhang1, Ni An1, Yong Tao1, Wei-Feng Yu2, Fei-Xiang Wu3.   

Abstract

Postoperative acute renal failure in patients with obstructive jaundice is still a serious clinically complication, yet the mechanisms remain unclear. Renin-angiotensin-aldosterone system (RAAS) plays a central role in renal disease progression. Several lines of evidence shows that angiotensin-converting-enzyme-2 (ACE2), a main effector of RAAS acts as a local regulator for renal protection. This study aims to investigate the role of ACE2 and the effect of spironolactone treatment in obstructive jaundice(OJ) rats with renal injury. The rats with obstructive jaundice were established by bile duct ligation. Total bilirubin (TBil), serum creatinine (Scr) and the expression of ACE2 in kidney tissue of obstructive jaundice rats were detected. Comparatively, the expression of ACE2, renin, angiotensin II (AngII), angiotensin-(1-7)[Ang-(1-7)], aldosterone and intercellular adhesion molecule 1 (ICAM-1) in kidney tissues after spironolactone administration were measured by ELISA. Renal necrosis, inflammation and fibrosis induced by OJ were also measured by HE staining and Masson staining. The correlation between the expression of ACE2 and TBil, also the Scr level were investigated. With the time of common bile duct ligation prolonged, the TBil and Scr concentration increased while the expression of ACE2 in OJ rats' kidney tissues decreased. However, after spironolactone intervention, the expressions of ACE2, renin, AngII, Ang-(1-7), aldosterone and ICAM-1 in kidney tissue were changed, moreover, necrotic, inflammatory and fibrotic condition was also decreased. The relationship between the mRNA expression of ACE2 and TBil/Scr was observed to be moderately negatively correlated (r = -0.516, R2 = 0.292, P < 0.01), (r = -0.576, R2 = 0.332, P < 0.01), respectively. RAAS exerted an important effect in the renal damage caused by OJ. Spironolactone intervention not only improved the degree of renal fibrosis induced by OJ, but also upregulated the ACE2 expression in the kidney of OJ rats and rescued the renal function.

Entities:  

Keywords:  Angiotensin-converting-enzyme-2 (ACE2); Obstructive jaundice (OJ); Renal function; Renin-angiotensin-aldosterone system (RAAS); Spironolactone

Year:  2018        PMID: 29882088      PMCID: PMC6381374          DOI: 10.1007/s12079-018-0466-2

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  34 in total

1.  Role of aldosterone in diabetic nephropathy.

Authors:  Dae Ryong Cha; Young Sun Kang; Sang Youb Han; Yi Hwa Jee; Kum Hyun Han; Hyoung Kyu Kim; Jee Young Han; Young Sik Kim
Journal:  Nephrology (Carlton)       Date:  2005-10       Impact factor: 2.506

Review 2.  Aldosterone in renal disease.

Authors:  T H Hostetter; M E Rosenberg; H N Ibrahim; I Juknevicius
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-01       Impact factor: 2.894

3.  A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase.

Authors:  S R Tipnis; N M Hooper; R Hyde; E Karran; G Christie; A J Turner
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

4.  Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio.

Authors:  Shigeyuki Wakahara; Tadashi Konoshita; Shinichi Mizuno; Makoto Motomura; Chikako Aoyama; Yasukazu Makino; Norihiro Kato; Ichiro Koni; Isamu Miyamori
Journal:  Endocrinology       Date:  2007-02-15       Impact factor: 4.736

5.  Are bile acids involved in the renal dysfunction of obstructive jaundice? An experimental study in bile duct ligated rats.

Authors:  Balwant Kaler; Tony Karram; Winston A Morgan; Peter H Bach; Ibrahaim M Yousef; Arieh Bomzon
Journal:  Ren Fail       Date:  2004-09       Impact factor: 2.606

6.  Multivariate analysis of factors associated with renal dysfunction in patients with obstructive jaundice.

Authors:  F J Padillo; A Cruz; J Briceño; A Martin-Malo; C Pera-Madrazo; A Sitges-Serra
Journal:  Br J Surg       Date:  2005-11       Impact factor: 6.939

7.  Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins.

Authors:  Mary Donoghue; Hiroko Wakimoto; Colin T Maguire; Susan Acton; Paul Hales; Nancy Stagliano; Victoria Fairchild-Huntress; Jian Xu; John N Lorenz; Vivek Kadambi; Charles I Berul; Roger E Breitbart
Journal:  J Mol Cell Cardiol       Date:  2003-09       Impact factor: 5.000

8.  Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells.

Authors:  Alessandra Caligiuri; Raffaella M s De Franco; Roberto G Romanelli; Alessandra Gentilini; Marta Meucci; Paola Failli; Luca Mazzetti; Krista Rombouts; Albert Geerts; Massimo Vanasia; Paolo Gentilini; Fabio Marra; Massimo Pinzani
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

9.  Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction.

Authors:  Howard Trachtman; Adam C Weiser; Elsa Valderrama; Maria Morgado; Lane S Palmer
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

Review 10.  Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function.

Authors:  Carlos M Ferrario; Aaron J Trask; Jewell A Jessup
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-29       Impact factor: 4.733

View more
  7 in total

1.  [Angiotensin-converting enzyme 2 particapates in ozone-induced lung inflammation and airway remodeling in mice].

Authors:  Y Wang; Y Zhang; L Zhang; M Li; P Zhu; W Ji; R Liang; L Qiin; W Wu; F Feng; Y Jin
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-06-20

2.  ACE2 Attenuates Epithelial-Mesenchymal Transition in MLE-12 Cells Induced by Silica.

Authors:  Shumin Li; Yaqian Li; Hong Xu; Zhongqiu Wei; Yi Yang; Fuyu Jin; Min Zhang; Chen Wang; Wenxiong Song; Jingchen Huo; Jingyuan Zhao; Xiuhong Yang; Fang Yang
Journal:  Drug Des Devel Ther       Date:  2020-04-21       Impact factor: 4.162

3.  Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies.

Authors:  Hisashi Kai; Mamiko Kai; Hiroshi Niiyama; Norihito Okina; Motoki Sasaki; Takanobu Maeda; Atsushi Katoh
Journal:  Hypertens Res       Date:  2021-03-10       Impact factor: 3.872

4.  Coronavirus-19: Possible Therapeutic Implications of Spironolactone and Dry Extract of Glycyrrhiza glabra L. (Licorice).

Authors:  Decio Armanini; Cristina Fiore; Jens Bielenberg; Chiara Sabbadin; Luciana Bordin
Journal:  Front Pharmacol       Date:  2020-10-22       Impact factor: 5.810

5.  Repurposing existing drugs for COVID-19: an endocrinology perspective.

Authors:  Flavio A Cadegiani
Journal:  BMC Endocr Disord       Date:  2020-09-29       Impact factor: 2.763

6.  Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review.

Authors:  Hajira Dambha-Miller; Ali Albasri; Sam Hodgson; Christopher R Wilcox; Shareen Khan; Nazrul Islam; Paul Little; Simon J Griffin
Journal:  BMJ Open       Date:  2020-09-14       Impact factor: 2.692

Review 7.  Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19.

Authors:  Shigeru Shibata; Hisatomi Arima; Kei Asayama; Satoshi Hoshide; Atsuhiro Ichihara; Toshihiko Ishimitsu; Kazuomi Kario; Takuya Kishi; Masaki Mogi; Akira Nishiyama; Mitsuru Ohishi; Takayoshi Ohkubo; Kouichi Tamura; Masami Tanaka; Eiichiro Yamamoto; Koichi Yamamoto; Hiroshi Itoh
Journal:  Hypertens Res       Date:  2020-07-31       Impact factor: 5.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.